{
    "nct_id": "NCT04842890",
    "official_title": "Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer",
    "inclusion_criteria": "* Biopsy-proven NCCN low- or intermediate-risk prostate cancer, which includes patients with:\n* Gleason score ≤7 disease\n* PSA ≤20 ng/ml\n* Clinical T1-T2c disease\n\n  * Note: Patients who only have radiographic evidence of possible or probable T3 disease (i.e., extracapsular extension or seminal vesical invasion) will not be excluded.\n* KPS ≥ 80%\n* Prostate size as determined on MRI to be < 100 cc. Prostate size can be determined on CT scan if MRI is not available.\n* Male 18 years of age or older\n* IPSS ≤ 20\n* Patient must be a candidate for and agree to placement of intraprostatic fiducial markers and a hydrogel rectal spacer\n* Patient must be available for at least 2 years of follow-up\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior prostate surgery (including cryosurgery)\n\n  * Note: Patients who underwent TURP or greenlight PVP are eligible if it was > 12 weeks prior to the anticipated start date of SBRT\n* Prior history of chronic prostatitis or urethral stricture\n* Currently active cancer(s) other than non-melanoma skin cancers. Patients are not considered to have currently active cancers if they have completed therapy and are considered by their physicians to be at <5% risk of relapse within 2 years.\n* Life expectancy of < 2 years",
    "miscellaneous_criteria": ""
}